Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.


Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

Twist Bioscience appoints chief ethics and compliance officer

Scuttlebutt | May 1, 2017

Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced the appointment of Mark Daniels to the newly created position of chief ethics and compliance officer.

Daniels will maintain his current position as Twist Bioscience’s general counsel. In his expanded role, he will oversee the company’s ethics and compliance programs.

“Our expanding role in the bioeconomy comes with incredible responsibility to continuously evaluate the ethical impact of our business and our actions,” said Twist Bioscience CEO Emily Leproust. “Importantly, we view ethics and compliance as integral to our operations, with a continued focus on demonstrated leadership in biosecurity and biosafety. Ethics and compliance will only become more important as we move forward with our pharmaceutical vertical.”


Read this single article for $49, or click the subscribe button below to review subscription options.

Enjoy unlimited access to thousands of articles, browse five years of digital magazines, qualify for reduced admission to events, and more.